Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -

NCT00485069 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00485069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00485069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2009
Enrollment
123 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, parkinson's disease